Capital Flow Monitor · Sponsors · CIK 1992812
Automera US Inc.
2815 EASTLAKE AVE E #300, SEATTLE, WA, 98102 · 206-957-7300
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$7.0M
Sold
$1.0M
% sold
14.3%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | D ·current | 506(b) | $7.0M | $1.0M | 14.3% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Thong Le — Executive Officer / Director / Promoter, Seattle, WA
- Mitchell Hymowitz — Executive Officer, Seattle, WA
- Suzanne Rettenmier — Executive Officer, Seattle, WA
- Yu-Chieh Alice Chen — Director, Seattle, WA
-
Benjamin Zian-Loong Wang — Director, Seattle, WA
1 other raise
- Nexus Networks, Inc. $26.4M of $32.5M · 81.2%
-
Sean Cassidy — Director, Seattle, WA
4 other raises
- Lucem Health, Inc. $8.4M of $8.4M · 100.0%
- Quarry Heme, Inc $13.5M of $13.5M · 100.0%
- Quarry DAC, Inc $2.1M of $2.1M · 100.0%
- Duracrin, LLC $1.0M of $1.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.